Sai Parenterals to acquire stake in Bion Therapeutics

In Short

The acquisition, expected to be completed before the end of November, will make Bion a step-down subsidiary of Sai Parenterals. The company has not disclosed the financial consideration or the exact stake being acquired.

Sai Parenterals to acquire stake in Bion Therapeutics
X

Sai Parenterals to acquire stake in Bion Therapeutics

Font size
FOLLOW ON Google News

Hyderabad: Sai Parenterals Limited, through its wholly owned subsidiary SP Analytics Private Limited, has signed a definitive agreement to acquire a majority stake in Hyderabad-based Bion Therapeutics India Private Limited in an all-cash transaction.

The acquisition, expected to be completed before the end of November, will make Bion a step-down subsidiary of Sai Parenterals. The company has not disclosed the financial consideration or the exact stake being acquired.

Anil Kumar Karusala, Chairman &MD, Sai Parenterals, said:“This acquisition completes the platform we have been building. Over the past year we haveexpanded capacity at Unit III, begun construction of the critical-care injectable facility atGummadidala, consolidated all our research at Sai Prathyak, and strengthened the Noumed platform in Australia and New Zealand. Each of these strengthens what we are able to developand manufacture. Bion provides the route to take them to the Indian market directly,converting development capability into branded revenue.”

Laxman Prasad Shukla, MD, Bion Therapeutics, said: “Joining the Sai Parenterals Group addresses the constraint we have felt most acutely: accessto manufacturing depth and a development pipeline at the scale our market positionwarrants. Our team will continue to lead the business and its relationships. What changes isthe breadth of the portfolio they are able to take to market.”

The Hans India
ABOUT THE AUTHOR

The Hans India

Next Story
Share it